JP4757797B2 - 無水環状ホスホン酸の製造法 - Google Patents
無水環状ホスホン酸の製造法 Download PDFInfo
- Publication number
- JP4757797B2 JP4757797B2 JP2006520716A JP2006520716A JP4757797B2 JP 4757797 B2 JP4757797 B2 JP 4757797B2 JP 2006520716 A JP2006520716 A JP 2006520716A JP 2006520716 A JP2006520716 A JP 2006520716A JP 4757797 B2 JP4757797 B2 JP 4757797B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- anhydride
- cyclic
- phosphonic
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 125000004122 cyclic group Chemical group 0.000 title claims abstract description 22
- XNQULTQRGBXLIA-UHFFFAOYSA-O phosphonic anhydride Chemical compound O[P+](O)=O XNQULTQRGBXLIA-UHFFFAOYSA-O 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims abstract description 77
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 20
- 238000004821 distillation Methods 0.000 claims abstract description 19
- 239000003960 organic solvent Substances 0.000 claims abstract description 10
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims abstract description 7
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 4
- 125000005336 allyloxy group Chemical group 0.000 claims abstract description 4
- 125000003118 aryl group Chemical group 0.000 claims abstract description 4
- 125000004104 aryloxy group Chemical group 0.000 claims abstract description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims abstract description 3
- 150000003007 phosphonic acid derivatives Chemical class 0.000 claims abstract 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 238000000066 reactive distillation Methods 0.000 claims description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 7
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 7
- 239000013638 trimer Substances 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 6
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 5
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 3
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 claims description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 3
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 claims description 3
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims description 3
- 229940090181 propyl acetate Drugs 0.000 claims description 3
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 claims description 3
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 2
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical compound C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004914 cyclooctane Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 2
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 claims 1
- -1 or open-chain Chemical group 0.000 abstract description 4
- 238000006482 condensation reaction Methods 0.000 abstract description 3
- 230000010933 acylation Effects 0.000 abstract description 2
- 238000005917 acylation reaction Methods 0.000 abstract description 2
- 229960000583 acetic acid Drugs 0.000 abstract 1
- 235000011054 acetic acid Nutrition 0.000 abstract 1
- 229940042400 direct acting antivirals phosphonic acid derivative Drugs 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 description 17
- 238000003786 synthesis reaction Methods 0.000 description 14
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 10
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 230000008020 evaporation Effects 0.000 description 8
- PAQZWJGSJMLPMG-UHFFFAOYSA-N 2,4,6-tripropyl-1,3,5,2$l^{5},4$l^{5},6$l^{5}-trioxatriphosphinane 2,4,6-trioxide Chemical compound CCCP1(=O)OP(=O)(CCC)OP(=O)(CCC)O1 PAQZWJGSJMLPMG-UHFFFAOYSA-N 0.000 description 6
- NNGDPBGHQANKAC-OALUTQOASA-N methyl (2s)-2-[[(2s)-2-acetamido-3-phenylpropanoyl]amino]-3-phenylpropanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(C)=O)C1=CC=CC=C1 NNGDPBGHQANKAC-OALUTQOASA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 229910052786 argon Inorganic materials 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- CBQJSKKFNMDLON-JTQLQIEISA-N N-acetyl-L-phenylalanine Chemical compound CC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 CBQJSKKFNMDLON-JTQLQIEISA-N 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- SWVMLNPDTIFDDY-FVGYRXGTSA-N methyl (2s)-2-amino-3-phenylpropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CC1=CC=CC=C1 SWVMLNPDTIFDDY-FVGYRXGTSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- FIQDWOOZBLBKHW-UHFFFAOYSA-N 2,4,6-tricyclohexyl-1,3,5,2$l^{5},4$l^{5},6$l^{5}-trioxatriphosphinane 2,4,6-trioxide Chemical compound O1P(=O)(C2CCCCC2)OP(=O)(C2CCCCC2)OP1(=O)C1CCCCC1 FIQDWOOZBLBKHW-UHFFFAOYSA-N 0.000 description 2
- KGMOTOPNEPTZJH-UHFFFAOYSA-N 2,4,6-triethyl-1,3,5,2$l^{5},4$l^{5},6$l^{5}-trioxatriphosphinane 2,4,6-trioxide Chemical compound CCP1(=O)OP(=O)(CC)OP(=O)(CC)O1 KGMOTOPNEPTZJH-UHFFFAOYSA-N 0.000 description 2
- FLKNXIIHNQWXGR-UHFFFAOYSA-N 2,4,6-trihexyl-1,3,5,2$l^{5},4$l^{5},6$l^{5}-trioxatriphosphinane 2,4,6-trioxide Chemical compound CCCCCCP1(=O)OP(=O)(CCCCCC)OP(=O)(CCCCCC)O1 FLKNXIIHNQWXGR-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- VKFDJBFIVUKVCL-GWCFXTLKSA-N methyl (2s)-2-[[(2s)-2-acetamido-3-phenylpropanoyl]amino]propanoate Chemical compound COC(=O)[C@H](C)NC(=O)[C@@H](NC(C)=O)CC1=CC=CC=C1 VKFDJBFIVUKVCL-GWCFXTLKSA-N 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- NSETWVJZUWGCKE-UHFFFAOYSA-N propylphosphonic acid Chemical compound CCCP(O)(O)=O NSETWVJZUWGCKE-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- RWLBSUQMKTYRRA-UHFFFAOYSA-N O=P1OP(=O)OP(=O)O1 Chemical class O=P1OP(=O)OP(=O)O1 RWLBSUQMKTYRRA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- FBSFTJQYCLLGKH-UHFFFAOYSA-N cyclohexylphosphonic acid Chemical compound OP(O)(=O)C1CCCCC1 FBSFTJQYCLLGKH-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- GATNOFPXSDHULC-UHFFFAOYSA-N ethylphosphonic acid Chemical compound CCP(O)(O)=O GATNOFPXSDHULC-UHFFFAOYSA-N 0.000 description 1
- 238000012851 eutrophication Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- GJWAEWLHSDGBGG-UHFFFAOYSA-N hexylphosphonic acid Chemical compound CCCCCCP(O)(O)=O GJWAEWLHSDGBGG-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- IYUKFAFDFHZKPI-DFWYDOINSA-N methyl (2s)-2-aminopropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@H](C)N IYUKFAFDFHZKPI-DFWYDOINSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 125000005499 phosphonyl group Chemical group 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000002341 toxic gas Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3895—Pyrophosphonic acids; phosphonic acid anhydrides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/10—Process efficiency
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
Description
a)式(I)のホスホン酸アルカンを無水酢酸と温度30〜150℃で反応させ、同時に酢酸と無水酢酸の混合物を蒸留により除去すること、
b)続いて、工程a)で得られた式(II)のオリゴマー状無水ホスホン酸を反応的蒸留にかけ、対応する式(III)の環状三量体状無水ホスホン酸に転化すること、
により製造することにより、達成され、ここで
nは0〜300の整数であり、
Rは、H、フッ素、塩素、臭素、ヨウ素、アリル、アリール、開鎖または分岐したC1〜C8アルキル基、アリールオキシ、アリルオキシまたは開環または分岐したC1〜C8アルキル基を有するアルコキシ、ニトロ、ニトリル、カルボキシ、開鎖または分岐したC1〜C8アルキル基を有するカルボン酸エステル、アミドまたは開鎖または分岐したC1〜C8アルキル基を有するアルキルアミド基である。
a)式(I)のホスホン酸を縮合させ、式(II)のOPAを形成し、同時に酢酸および未転化無水酢酸を30℃〜150℃(反応器内部温度)または30℃〜130℃(最上部温度)、好ましくは50℃〜130℃(反応器内部温度)または35℃〜100℃(最上部温度)、最も好ましくは70℃〜110℃(反応器内部温度)または40℃〜70℃(最上部温度)で蒸留すること、および
b)式(II)のOPAを、100℃〜450℃(反応器内部温度)または100℃〜380℃(最上部温度)、好ましくは150℃〜400℃(反応器内部温度)または150℃〜350℃(最上部温度)、より好ましくは200℃〜350℃(反応器内部温度)または200℃〜300℃(最上部温度)で反応的蒸留にかけ、式(III)のCPAを形成すること
からなる2段階で行う。
a)酢酸および無水酢酸の蒸留は、100時間以内、好ましくは80時間以内、より好ましくは60時間以内、で行い、
b)式(II)のOPAから式(III)のCPAへの反応的蒸留は、120時間以内、好ましくは90時間以内、より好ましくは60時間以内、で行う
ことが多い。
例1 2,4,6−トリプロピル−[1,3,5,2,4,6]−トリオキサトリホスフィナン2,4,6−トリオキシドの合成
攪拌機、栓、内部温度計および蒸留カラムを備えたガラス製フラスコ中で、プロパンホスホン酸33.0g(0.27mol)を、アルゴン下で無水酢酸189.3g(1.85mol)中に溶解させ、2時間還流加熱する。続いて、酢酸と無水酢酸の混合物を100mbarで留別する。外部温度を350℃に、真空を0.1mbarに増加する。最上部温度280℃で、無色、シロップ状の2,4,6−トリプロピル−[1,3,5,2,4,6]−トリオキサトリホスフィナン2,4,6−トリオキシド22.9gが得られる(収率80%)。
攪拌機、栓、内部温度計および蒸留カラムを備えたガラス製フラスコ中で、プロパンホスホン酸33.0g(0.27mol)を、アルゴン下で無水酢酸189.3g(1.85mol)中に溶解させ、2時間還流加熱する。続いて、酢酸と無水酢酸の混合物を100mbarで留別する。外部温度を350℃に、真空を0.1mbarに増加する。最上部温度280℃で、無色、シロップ状の2,4,6−トリプロピル−[1,3,5,2,4,6]−トリオキサトリホスフィナン2,4,6−トリオキシド22.9gが得られる(収率80%)。
攪拌機、栓、内部温度計および蒸留カラムを備えたガラス製フラスコ中で、エタンホスホン酸40.2g(0.37mol)を、アルゴン下で無水酢酸204.9g(2.01mol)中に溶解させ、2時間還流加熱する。続いて、酢酸と無水酢酸の混合物を100mbarで留別する。外部温度を350℃に、真空を0.1mbarに増加する。最上部温度295℃で、無色、シロップ状の2,4,6−トリエチル−[1,3,5,2,4,6]−トリオキサトリホスフィナン2,4,6−トリオキシド20.2gが得られる(収率66%)。
攪拌機、栓、内部温度計および蒸留カラムを備えたガラス製フラスコ中で、ヘキサンホスホン酸44.8g(0.27mol)を、アルゴン下で無水酢酸189.3g(1.85mol)中に溶解させ、2時間還流加熱する。続いて、酢酸と無水酢酸の混合物を100mbarで留別する。外部温度を350℃に、真空を0.1mbarに増加する。最上部温度240℃で、無色、シロップ状の2,4,6−トリヘキシル−[1,3,5,2,4,6]−トリオキサトリホスフィナン2,4,6−トリオキシド30.0gが得られる(収率75%)。
攪拌機、栓、内部温度計および蒸留カラムを備えたガラス製フラスコ中で、シクロヘキサンホスホン酸44.3g(0.27mol)を、アルゴン下で無水酢酸189.3g(1.85mol)中に溶解させ、2時間還流加熱する。続いて、酢酸と無水酢酸の混合物を100mbarで留別する。外部温度を350℃に、真空を0.1mbarに増加する。最上部温度260℃で、無色、シロップ状の2,4,6−トリシクロヘキシル−[1,3,5,2,4,6]−トリオキサトリホスフィナン2,4,6−トリオキシド27.6gが得られる(収率75%)。
L−アラニンメチルエステルヒドロクロリド0.1g(0.7mmol)、N−アセチル−L−フェニルアラニン0.2g(1mmol)およびN−メチルモルホリン0.55ml(5mmol)をジクロロメタン50mlに溶解させ、−10℃に冷却する。例1から得たCPA0.5g(CH2Cl2中50%、0.8mmol)を徐々に加え、混合物を低温条件下で3時間、および室温で72時間攪拌する。この溶液を蒸発により濃縮し、酢酸エチルおよび1N HCl溶液、飽和NaHCO3、飽和NaClおよび蒸留水で抽出する。有機相を硫酸マグネシウム上で除湿し、濾別し、蒸発により濃縮する。白色のN−アセチル−L−フェニルアラニニル−L−アラニンメチルエステル0.18gが得られる(88%)。
L−フェニルアラニンメチルエステルヒドロクロリド0.38g(1.8mmol)、N−アセチル−L−フェニルアラニン0.37g(1.7mmol)およびN−メチルモルホリン1.6ml(14.6mmol)をジメチルアセトアミド30mlに溶解させ、0℃に冷却する。次いで、例2から得たCPA1.2ml(ジメチルホルムアミド中50%、1.9mmol)を加える。混合物を0°でさらに1時間、および室温で12時間攪拌する。この溶液を蒸発により濃縮し、酢酸エチルおよび1N HCl溶液、飽和NaHCO3、飽和NaClおよび蒸留水で抽出する。有機相を硫酸マグネシウム上で除湿し、濾別し、蒸発により濃縮する。白色のN−アセチル−L−フェニルアラニニル−L−フェニルアラニンメチルエステル0.53gが得られる(84%)。
L−フェニルアラニンメチルエステルヒドロクロリド0.38g(1.8mmol)、N−アセチル−L−フェニルアラニン0.37g(1.7mmol)およびN−メチルモルホリン1.6ml(14.6mmol)をジメチルアセトアミド30mlに溶解させ、0℃に冷却する。次いで、ヨーロッパ特許第0527442号、例1に記載されているようにして製造したOPA1.2ml(ジメチルホルムアミド中50%、組成が不明なので、モル量は記載できない)を加える。混合物を0°でさらに1時間、および室温で12時間攪拌する。この溶液を蒸発により濃縮し、酢酸エチルおよび1N HCl溶液、飽和NaHCO3、飽和NaClおよび蒸留水で抽出する。有機相を硫酸マグネシウム上で除湿し、濾別し、蒸発により濃縮する。白色のN−アセチル−L−フェニルアラニニル−L−フェニルアラニンメチルエステル0.14gが得られる(22%)。
L−フェニルアラニンメチルエステルヒドロクロリド0.38g(1.8mmol)、N−アセチル−L−フェニルアラニン0.37g(1.7mmol)およびN−メチルモルホリン5.0ml(45.5mmol)をジメチルアセトアミド30mlに溶解させ、0℃に冷却する。次いで、ヨーロッパ特許第0527442号、例1に記載されているようにして製造したOPA5ml(ジメチルホルムアミド中50%、組成が不明なので、モル量は記載できない)を加える。混合物を0°でさらに1時間、および室温で12時間攪拌する。この溶液を蒸発により濃縮し、酢酸エチルおよび1N HCl溶液、飽和NaHCO3、飽和NaClおよび蒸留水で抽出する。有機相を硫酸マグネシウム上で除湿し、濾別し、蒸発により濃縮する。白色のN−アセチル−L−フェニルアラニニル−L−フェニルアラニンメチルエステル0.55gが得られる(87%)。
Claims (7)
- a)式(I)のホスホン酸誘導体を無水酢酸と温度30〜150℃で反応させ、同時に酢酸と無水酢酸の混合物を蒸留により除去すること、
b)続いて、工程a)で得られた式(II)のオリゴマー状無水ホスホン酸を反応的蒸留にかけ、対応する式(III)の環状三量体状無水ホスホン酸に転化し、形成された環状三量体状無水ホスホン酸を、環状三量体状無水ホスホン酸に対して不活性な有機溶剤に直ちに溶解させること、
により、式(III)の無水環状ホスホン酸を製造する方法。
nは0〜300の整数であり、
Rは、アリル、アリール、または開鎖環状または分岐したC1〜C8アルキル基、アリールオキシ、アリルオキシまたは開鎖環状または分岐したC1〜C8アルキル基を有するアルコキシである) - 無水酢酸と式(I)のホスホン酸の比が20:1〜1:1である、請求項1に記載の方法。
- 工程b)における反応的蒸留が、温度100〜450℃(内部反応器温度)および最上部温度100〜380℃で行われる、請求項1または2に記載の方法。
- a)酢酸および未転化無水酢酸の蒸留における圧力が1mbar〜1000mbarであり、b)式(II)のオリゴマー状無水ホスホン酸から式(III)の環状無水ホスホン酸への反応的蒸留における圧力が0.001mbar〜500mbarである、請求項1〜3のいずれか一項に記載の方法。
- 連続的に行われる、請求項1〜4のいずれか一項に記載の方法。
- 得られた式(III)の環状三量体状無水ホスホン酸を、反応的蒸留の後、有機溶剤中に、溶剤と無水ホスホン酸の混合比10:1〜1:10で溶解させる、請求項1〜5のいずれか一項に記載の方法。
- 前記有機溶剤が、リグロイン、スルホラン、DMSO、HMPT、NMP、ペンタン、ヘキサン、ヘプタン、オクタン、シクロペンタン、シクロヘキサン、シクロヘプタン、シクロオクタン、ジクロロメタン、クロロホルム、四塩化炭素、1,2−ジクロロエタン、1,1,2,2−テトラクロロエタン、酢酸メチル、酢酸エチル、酢酸プロピル、酢酸ブチル、ジメチルホルムアミド、ジエチルホルムアミド、ジメチルアセトアミド、ジエチルアセトアミド、ジエチルエーテル、ジイソプロピルエーテル、tert−ブチルメチルエーテル、THF、ジオキサン、アセトニトリル、スルホラン、DMSO、HMPT、NMPまたはそれらの混合物である、請求項1〜6のいずれか一項に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10333042.9 | 2003-07-21 | ||
DE10333042A DE10333042B4 (de) | 2003-07-21 | 2003-07-21 | Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden und deren Verwendung |
PCT/EP2004/007468 WO2005014604A2 (de) | 2003-07-21 | 2004-07-08 | Verfahren zur herstellung von cyclischen phosphonsäureanhydriden |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006528140A JP2006528140A (ja) | 2006-12-14 |
JP4757797B2 true JP4757797B2 (ja) | 2011-08-24 |
Family
ID=34111622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006520716A Expired - Lifetime JP4757797B2 (ja) | 2003-07-21 | 2004-07-08 | 無水環状ホスホン酸の製造法 |
Country Status (14)
Country | Link |
---|---|
US (2) | US7473794B2 (ja) |
EP (1) | EP1658299B1 (ja) |
JP (1) | JP4757797B2 (ja) |
KR (1) | KR20060063906A (ja) |
CN (1) | CN100387606C (ja) |
AT (1) | ATE443710T1 (ja) |
AU (1) | AU2004263226A1 (ja) |
BR (1) | BRPI0412747A (ja) |
CA (1) | CA2533173A1 (ja) |
DE (2) | DE10333042B4 (ja) |
ES (1) | ES2331074T3 (ja) |
HK (1) | HK1093989A1 (ja) |
MX (1) | MXPA06000788A (ja) |
WO (1) | WO2005014604A2 (ja) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10333042B4 (de) * | 2003-07-21 | 2005-09-29 | Clariant Gmbh | Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden und deren Verwendung |
DE102008003677A1 (de) * | 2008-01-09 | 2009-07-16 | Archimica Gmbh | Verfahren zur Herstellung von Phosphonsäureanhydriden |
FR2928148B1 (fr) * | 2008-02-28 | 2013-01-18 | Sanofi Aventis | Procede de preparation de combretastatine |
EP2303900A2 (en) * | 2008-06-09 | 2011-04-06 | Celtic Catalysts Limited | Process |
CN102177164B (zh) | 2008-11-05 | 2015-02-11 | 科莱恩金融(Bvi)有限公司 | 利用烯丙醇/丙烯醛制备二烷基次膦酸、二烷基次膦酸酯和二烷基次膦酸盐的方法,以及它们的用途 |
DE102008055914A1 (de) * | 2008-11-05 | 2010-05-06 | Clariant International Limited | Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acroleinen und ihre Verwendung |
DE102008055916A1 (de) * | 2008-11-05 | 2010-05-06 | Clariant International Limited | Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Allylalkoholen und ihre Verwendung |
DE102008056339A1 (de) * | 2008-11-07 | 2010-05-12 | Clariant International Limited | Verfahren zur Herstellung von mono-aminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung |
DE102008056341A1 (de) | 2008-11-07 | 2010-05-12 | Clariant International Limited | Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung |
EP2352740B1 (de) * | 2008-11-07 | 2014-09-24 | Clariant Finance (BVI) Limited | Verfahren zur herstellung von dialkylphosphinsäuren, -estern und -salzen mittels acrylsäurederivaten und ihre verwendung |
DE102008056342A1 (de) * | 2008-11-07 | 2010-05-12 | Clariant International Limited | Verfahren zur Herstellung von Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung |
US8772519B2 (en) | 2008-11-11 | 2014-07-08 | Clariant Finance (Bvi) Limited | Process for preparing mono-allyl-functionalized dialkylphosphinic acids, salts and esters thereof with allylic compounds, and the use thereof |
DE102008060035A1 (de) * | 2008-12-02 | 2010-06-10 | Clariant International Limited | Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung |
DE102008060036A1 (de) * | 2008-12-02 | 2010-06-10 | Clariant International Limited | Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung |
DE102008060535A1 (de) | 2008-12-04 | 2010-06-10 | Clariant International Limited | Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylether und ihre Verwendung |
DE102008063627A1 (de) | 2008-12-18 | 2010-06-24 | Clariant International Limited | Verfahren zur Herstellung von monohydroxyfunktionalisierten Dialkylphosphinsäuren,-estern und -salzen mittels Ethylenoxid und ihre Verwendung |
DE102008063668A1 (de) | 2008-12-18 | 2010-07-01 | Clariant International Limited | Verfahren zur Herstellung von Alkylphosponsäuren, -estern und -salzen mittels Oxidation von Alkylphosphonigsäuren und ihre Verwendung |
DE102008063642A1 (de) | 2008-12-18 | 2010-06-24 | Clariant International Limited | Verfahren zur Herstellung von monocarboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Alkylenoxiden und ihre Verwendung |
ES2446666T3 (es) | 2008-12-18 | 2014-03-10 | Clariant Finance (Bvi) Limited | Procedimiento para la preparación de ácidos etilen-dialquil-fosfínicos, o de sus ésteres y sales, mediante acetileno, y su utilización |
DE102008064012A1 (de) | 2008-12-19 | 2010-06-24 | Clariant International Limited | Halogenfreie Addukte von Alkylphosphonigsäurederivaten und diesterbildenden Olefinen, halogenfreie Verfahren zu deren Herstellung und ihre Verwendung |
DE102008064003A1 (de) | 2008-12-19 | 2010-06-24 | Clariant International Limited | Verfahren zur Herstellung von mono-funktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung |
WO2011110199A1 (en) | 2010-03-10 | 2011-09-15 | Synthon B.V. | A process for amidation of pyrrole carboxylate compounds |
WO2012048745A1 (en) | 2010-10-14 | 2012-04-19 | Synthon Bv | Process for making bortezomib and intermediates for the process |
DE102011108324A1 (de) * | 2011-07-25 | 2013-01-31 | Merck Patent Gmbh | Verfahren zur Herstellung von Bis(perfluoralkyl)phosphinsäureanhydriden |
CN103483386B (zh) * | 2013-08-30 | 2016-03-02 | 山东汇海医药化工有限公司 | 一种改进的1-丙基膦酸环酐的制备方法 |
CN107331893B (zh) * | 2016-04-29 | 2020-03-10 | 华为技术有限公司 | 一种高温锂离子电池电解液及其制备方法和高温锂离子电池 |
CN107011384B (zh) * | 2017-04-24 | 2019-02-15 | 中节能万润股份有限公司 | 一种环状丙基膦酸酐的制备方法 |
WO2019038406A1 (en) | 2017-08-25 | 2019-02-28 | Synthon B.V. | PROCESS FOR THE PREPARATION OF IXAZOMIB OR ITS INTERMEDIATES |
CN108314693B (zh) * | 2018-01-09 | 2020-06-09 | 苏州亚科科技股份有限公司 | 一种提高烷基膦酸酐衍生物稳定性的方法 |
US11608306B2 (en) | 2020-05-08 | 2023-03-21 | Hyconix, Inc. | Process for generating acid anhydrides |
CN111635434B (zh) * | 2020-07-20 | 2023-04-07 | 苏州昊帆生物股份有限公司 | 1-丙基磷酸环酐的合成方法 |
CN113185622B (zh) * | 2021-04-29 | 2022-05-24 | 华南理工大学 | 一种高磷含量壳聚糖衍生物及其制备与在负载纳米零价铁中的应用 |
KR102464766B1 (ko) * | 2021-07-09 | 2022-11-07 | 동우 화인켐 주식회사 | 전해액 조성물 및 이를 포함하는 이차전지 |
CN114195826B (zh) * | 2021-09-13 | 2023-06-23 | 洪湖市一泰科技有限公司 | 一种环膦酸酐生产中的蒸馏釜残留物的处理方法及处理装置 |
CN114763364A (zh) * | 2021-11-18 | 2022-07-19 | 黑龙江豪运药业有限公司 | 一种1-丙基磷酸酐的合成方法 |
CN115253339B (zh) * | 2022-07-21 | 2024-04-12 | 西安彩晶光电科技股份有限公司 | 一种1-丙基磷酸环酐的生产装置及工艺 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60218399A (ja) * | 1984-03-27 | 1985-11-01 | ヘキスト・アクチエンゲゼルシヤフト | ペプチド中間体の製法 |
JPH01279921A (ja) * | 1988-05-06 | 1989-11-10 | Idemitsu Kosan Co Ltd | ポリアミドの製造方法 |
JPH05209057A (ja) * | 1991-08-08 | 1993-08-20 | Hoechst Ag | 純粋なプロパンホスホン酸無水物の製造方法 |
JPH09157284A (ja) * | 1995-12-11 | 1997-06-17 | Ono Pharmaceut Co Ltd | グルコピラノース誘導体の製造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2758580A1 (de) | 1977-12-29 | 1979-07-05 | Hoechst Ag | Verfahren zur herstellung von phosphin- und phosphonsaeure-anhydriden |
DE2811628A1 (de) * | 1978-03-17 | 1979-09-27 | Hoechst Ag | Alkan-bis-alkyl-phosphinsaeureanhydride und verfahren zur herstellung von alkanphosphon- und alkan-bis-alkylphosphinsaeureanhydriden |
US5191065A (en) * | 1988-11-22 | 1993-03-02 | Hoechst Aktiengesellschaft | Process for the preparation of tripeptides |
JPH0686478A (ja) | 1991-08-29 | 1994-03-25 | Nec Home Electron Ltd | 電子機器 |
DE19802969A1 (de) | 1998-01-27 | 1999-07-29 | Hoechst Marion Roussel De Gmbh | Verfahren zur Herstellung von S-Alkyl(Aryl)-substituierten Imidazol-Derivaten |
DE10063493A1 (de) | 2000-12-20 | 2002-06-27 | Bayer Ag | Verfahren zur Herstellung von substituierten Arylketonen |
DE10333042B4 (de) * | 2003-07-21 | 2005-09-29 | Clariant Gmbh | Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden und deren Verwendung |
-
2003
- 2003-07-21 DE DE10333042A patent/DE10333042B4/de not_active Expired - Fee Related
-
2004
- 2004-07-08 DE DE502004010124T patent/DE502004010124D1/de not_active Expired - Lifetime
- 2004-07-08 CN CNB2004800199255A patent/CN100387606C/zh not_active Expired - Fee Related
- 2004-07-08 AU AU2004263226A patent/AU2004263226A1/en not_active Abandoned
- 2004-07-08 KR KR1020067001379A patent/KR20060063906A/ko not_active Application Discontinuation
- 2004-07-08 EP EP04740776A patent/EP1658299B1/de not_active Expired - Lifetime
- 2004-07-08 ES ES04740776T patent/ES2331074T3/es not_active Expired - Lifetime
- 2004-07-08 MX MXPA06000788A patent/MXPA06000788A/es active IP Right Grant
- 2004-07-08 AT AT04740776T patent/ATE443710T1/de not_active IP Right Cessation
- 2004-07-08 US US10/565,470 patent/US7473794B2/en active Active
- 2004-07-08 WO PCT/EP2004/007468 patent/WO2005014604A2/de active Application Filing
- 2004-07-08 JP JP2006520716A patent/JP4757797B2/ja not_active Expired - Lifetime
- 2004-07-08 CA CA002533173A patent/CA2533173A1/en not_active Abandoned
- 2004-07-08 BR BRPI0412747-1A patent/BRPI0412747A/pt not_active IP Right Cessation
-
2007
- 2007-01-10 HK HK07100313.3A patent/HK1093989A1/xx not_active IP Right Cessation
-
2008
- 2008-04-02 US US12/061,124 patent/US7829736B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60218399A (ja) * | 1984-03-27 | 1985-11-01 | ヘキスト・アクチエンゲゼルシヤフト | ペプチド中間体の製法 |
JPH01279921A (ja) * | 1988-05-06 | 1989-11-10 | Idemitsu Kosan Co Ltd | ポリアミドの製造方法 |
JPH05209057A (ja) * | 1991-08-08 | 1993-08-20 | Hoechst Ag | 純粋なプロパンホスホン酸無水物の製造方法 |
JPH09157284A (ja) * | 1995-12-11 | 1997-06-17 | Ono Pharmaceut Co Ltd | グルコピラノース誘導体の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
US20060264654A1 (en) | 2006-11-23 |
WO2005014604A2 (de) | 2005-02-17 |
BRPI0412747A (pt) | 2006-09-26 |
MXPA06000788A (es) | 2006-04-18 |
US20080183009A1 (en) | 2008-07-31 |
EP1658299A2 (de) | 2006-05-24 |
EP1658299B1 (de) | 2009-09-23 |
US7473794B2 (en) | 2009-01-06 |
DE10333042A1 (de) | 2005-03-03 |
CN100387606C (zh) | 2008-05-14 |
US7829736B2 (en) | 2010-11-09 |
ATE443710T1 (de) | 2009-10-15 |
JP2006528140A (ja) | 2006-12-14 |
AU2004263226A1 (en) | 2005-02-17 |
ES2331074T3 (es) | 2009-12-21 |
CN1823079A (zh) | 2006-08-23 |
HK1093989A1 (en) | 2007-03-16 |
DE502004010124D1 (de) | 2009-11-05 |
CA2533173A1 (en) | 2005-02-17 |
DE10333042B4 (de) | 2005-09-29 |
WO2005014604A3 (de) | 2005-05-06 |
KR20060063906A (ko) | 2006-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4757797B2 (ja) | 無水環状ホスホン酸の製造法 | |
AU2019421447A1 (en) | Method of producing L-glufosinate | |
US9120833B2 (en) | Polyfluoroalkylphosphonic acid ester and process for producing the same | |
Xiao et al. | A facile asymmetric synthesis of 1‐amino‐2, 2, 2‐trifluoroethanephosphonic acid | |
JP2018534260A (ja) | ホスフィネート類を製造する方法 | |
JP3315222B2 (ja) | α−フルオロ−β−ジカルボニル化合物の製造方法 | |
KR20000048656A (ko) | 알루미늄 디알킬 포스피네이트의 제조방법 | |
CN111943901B (zh) | 一种由炔酰胺直接合成噁唑烷-2,4-二酮类杂环化合物的方法 | |
JP3054163B2 (ja) | ホスフィン酸エステル含有n―アシル―2―アミノ酸アミド、その製造方法および前駆体としてのn―アシル―2―アミノ酸ニトリル | |
US20110166382A1 (en) | Processes for obtaining a phosphonic acid from a phosphonic acid anhydride | |
JPS603317B2 (ja) | 塩化ホスフアイトの製造方法 | |
KR100776105B1 (ko) | 메틸렌 비스포스폰산 염의 제조 방법 | |
JPH0737440B2 (ja) | スルホニウム化合物の製造方法 | |
CN1042337C (zh) | 生产n-膦酰基甲基甘氨腈的烷基酯的酸加成盐的方法 | |
KR101522464B1 (ko) | 아렌설포닉 에시드로부터 아렌설포닐 클로라이드를 얻는 새로운 방법 | |
KR20170132537A (ko) | 5-(c1~c4 알킬) 테트라졸의 합성방법 | |
JPH0415794B2 (ja) | ||
CN114644577A (zh) | 一种取代异腈化合物的环保制备方法 | |
JP2022163759A (ja) | 3-ヒドロキシ-2-ピラジンカルボキサミドの製造方法及びそれに適した組成物、並びに2-アミノマロンアミドの製造方法 | |
SU1432056A1 (ru) | Способ получени N-триметилсилилзамещенных амидов диалкилфосфинистых кислот | |
JPH09124569A (ja) | ベンズアミド誘導体の製造方法 | |
CA2151323A1 (en) | Process for the preparation of 2,2-dichloromalonic diesters | |
JP3921642B2 (ja) | ジクロロ化合物の製造方法 | |
JPH11269184A (ja) | ヘテロ環ビス(フォスフォン酸)誘導体の新規製造法 | |
KR20000017404A (ko) | 트리플루오로아세트산 테트라알킬플루오로 포름아미디늄 및 그의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060928 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060928 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070329 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20091203 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091211 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100311 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100318 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100406 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100806 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110506 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110601 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4757797 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140610 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |